A Phase 1 Study of Cizutamig in IgE Mediated Diseases
The purpose of this study is to evaluate the pharmacodynamics, safety, tolerability, pharmacokinetics, and immunogenicity of cizutamig in IgE Mediated Diseases.
History of documented (skin prick test, in vitro testing, or food challenge), on... [+6]
Elevated IgE levels for reasons other than the IgE mediated diseases [+19]